Bronchodilator Recommendation for Inhalation Injury
For an adult with inhalation injury and no obvious distress, administer nebulized salbutamol (albuterol) 2.5-5 mg via air-driven nebulizer, as bronchodilators are a standard component of inhalation injury management to prevent and treat bronchospasm from airway inflammation and debris.
Clinical Context and Rationale
Inhalation injury causes a cascade of pathophysiologic changes in the subglottic airways, including mucosal hyperemia, edema, increased mucus secretion, and potential airway obstruction from casts formed by epithelial debris and fibrin clots 1. Even without obvious distress, prophylactic bronchodilator therapy is warranted as part of multimodal treatment.
Specific Bronchodilator Selection
Primary Agent: Beta-2 Agonist
- Salbutamol (albuterol) 2.5-5 mg nebulized is the first-line bronchodilator
- This is consistently recommended across burn unit guidelines 2
- Addresses bronchospasm from airway inflammation and helps maintain airway patency
Delivery Method
- Use air-driven nebulizer, NOT oxygen-driven in the acute setting
- This is critical because inhalation injury patients may have carbon monoxide poisoning or potential for CO2 retention
- High-flow oxygen should be administered separately for carbon monoxide treatment 2
Dosing Frequency
- Administer every 4-6 hours initially 3
- Titrate based on clinical response and presence of bronchospasm
- Can increase to 5-10 mg doses if bronchospasm develops 1
Additional Considerations for Inhalation Injury
Combination Therapy
While your patient currently has no obvious distress, be prepared to add:
- Ipratropium bromide 500 µg if bronchospasm develops or worsens 3
- Combined β-agonist with anticholinergic therapy is recommended for more severe cases 3
Monitoring Parameters
Watch for:
- Development of bronchospasm (wheezing, increased work of breathing)
- Signs of airway obstruction (stridor, respiratory distress)
- Tachycardia or arrhythmias from β-agonist therapy
- Need for escalation to mechanical ventilation
Important Caveats
Avoid routine prophylactic bronchodilators in mechanically ventilated patients without obstructive disease - if your patient requires intubation, bronchodilators should only continue if there is documented bronchospasm (resistive pressure gradient >15 cm H2O) 4. However, inhalation injury is an exception to this rule given the specific pathophysiology.
Delivery device matters - if the patient requires intubation, use metered-dose inhaler with spacer (10-15 puffs = 900-1350 µg) rather than nebulizer for more efficient drug delivery 5, 6.
This is part of a broader treatment strategy - bronchodilators should be combined with:
- Nebulized heparin for fibrin casts (if present)
- Nebulized N-acetylcysteine for mucus clearance
- Bronchoscopy for airway debris removal
- High-flow oxygen for carbon monoxide treatment 2, 1
The absence of obvious distress does not preclude the need for bronchodilator therapy in inhalation injury, as airway changes can progress rapidly over the first 24-48 hours.